http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105037471-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J71-001 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-0016 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-0011 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-0055 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J71-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 |
| filingDate | 2015-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105037471-B |
| titleOfInvention | A kind of steroid antivirotic |
| abstract | The present invention relates to a kind of steroid antivirotic, wherein steroid compound has structure shown in Formulas I： Formulas I.The antivirotic of the present invention is used as active ingredient comprising any one or several in compound of formula I, its stereoisomer, geometric isomer, dynamic isomer, solvate, prodrug or its pharmaceutically acceptable salt.The compound of formula I of the present invention has extremely strong inhibitory activity to the Respiratory Syncytial Virus(RSV) (RSV) of Paramyxoviridae, and it can be as antiviral drugs or as the lead compound in antiviral drugs research. |
| priorityDate | 2014-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 38.